During treatment for IRDS/HMD, what SpO2 target is commonly aimed for?

Prepare for the Registered Respiratory Therapist CSE with comprehensive flashcards and multiple-choice questions, including hints and explanations. Ace your exam with confidence!

Multiple Choice

During treatment for IRDS/HMD, what SpO2 target is commonly aimed for?

Explanation:
When treating IRDS/HMD, the goal is to balance adequate oxygenation with avoiding oxygen-related injury. Keeping SpO2 in the high 80s to around 90% provides enough oxygen to tissues while reducing the risk of hyperoxia-driven complications like retinopathy of prematurity and bronchopulmonary dysplasia. An SpO2 around 89-90% is a commonly used target because it sits near the threshold that prevents hypoxemia without pushing oxygen exposure too high. Targets well above this (95-100% or 100%) raise the risk of oxygen toxicity, while targets much lower (80-85%) risk tissue hypoxia.

When treating IRDS/HMD, the goal is to balance adequate oxygenation with avoiding oxygen-related injury. Keeping SpO2 in the high 80s to around 90% provides enough oxygen to tissues while reducing the risk of hyperoxia-driven complications like retinopathy of prematurity and bronchopulmonary dysplasia. An SpO2 around 89-90% is a commonly used target because it sits near the threshold that prevents hypoxemia without pushing oxygen exposure too high. Targets well above this (95-100% or 100%) raise the risk of oxygen toxicity, while targets much lower (80-85%) risk tissue hypoxia.

More practice questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy